Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Icatibant Acetate Injection

Approval Number

国药准字H20223894

Company江苏豪森药业集团有限公司

Registration Date

November 30, 2022

Drug Information

Generic Name

醋酸艾替班特注射液

Dosage Form

注射剂

Strength

3ml:30mg（按C₅₉H₈₉N₁₉O₁₃S计）

Drug Type

化学药品

Registration Date

November 30, 2022

Company Information

Applicant Company

Company Name江苏豪森药业集团有限公司

Company Address

江苏省连云港经济技术开发区

Manufacturing Company

Company Name江苏恒瑞医药股份有限公司

Company Address

连云港经济技术开发区临港产业区东晋路

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy